NASDAQ:NTLA - Intellia Therapeutics Insider Trading Activity

$14.41
-0.46 (-3.09 %)
(As of 09/19/2019 04:00 PM ET)
Today's Range
$14.39
Now: $14.41
$15.04
50-Day Range
$12.9451
MA: $15.83
$18.50
52-Week Range
$11.03
Now: $14.41
$32.95
Volume274,549 shs
Average Volume561,752 shs
Market Capitalization$704.29 million
P/E RatioN/A
Dividend YieldN/A
Beta2.71

Insider Trades

Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling Activity

Insider Ownership Percentage: 4.10%

Intellia Therapeutics (NASDAQ NTLA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2019Andrew SchiermeierEVPBuy7,500$15.72$117,900.003,250  
7/16/2018Jean Francois FormelaDirectorSell6,686$31.17$208,402.62  
6/19/2018Jean Francois FormelaDirectorSell6,686$27.96$186,940.56  
5/16/2018Jean Francois FormelaDirectorSell6,686$25.04$167,417.44  
5/14/2018John M. LeonardInsiderSell8,400$24.00$201,600.00  
3/20/2018Jean Francois FormelaDirectorSell39,245$23.87$936,778.15  
1/29/2018Caribou Biosciences, Inc.Major ShareholderSell550,645$26.78$14,746,273.10  
12/12/2017Institutes For Biomed NovartisMajor ShareholderSell1,523,000$18.30$27,870,900.00  
12/8/2017Nessan BerminghamCEOSell336,783$20.78$6,998,350.74696,000  
12/6/2017Nessan BerminghamCEOSell111,500$20.34$2,267,910.00696,000  
7/11/2017Venture Fund Ix L.P. AtlasMajor ShareholderSell150,000$16.24$2,436,000.00  
3/10/2017Jean Francois FormelaDirectorSell21,132$13.91$293,946.12  
5/11/2016Bros. Advisors Lp BakerInsiderBuy200,000$18.00$3,600,000.00  
5/11/2016Carl L GordonDirectorBuy250,000$18.00$4,500,000.00  
5/11/2016Institutes For Biomed NovartisMajor ShareholderBuy277,777$18.00$4,999,986.00  
(Data available from 1/1/2013 forward)
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel